CCH  Coca Cola Hellenic Bottling Co

Exchange

NYSE

Sector

Consumer Non-Durables

Industry

Beverages (Production/Distribution)

Market Cap.

8.499B

Vuru Grade

53.43/100

Current Price

$23.33
0.00 (0.00%)

Growth Price

$28.43
Undervalued by 21.88%

Stability Price

$4.72
Overvalued by 79.75%

Company Metrics

  • 30.54 P/E
  • 0.93 P/S
  • 2.23 P/B
  • 0.764 EPS
  • 10.36% Cash ROIC
  • 0.36 Cash Ratio
  • 0.666 / 2.85% Dividend
  • 19,768.00 Avg. Vol.
  • 364.29M Shares
  • 8.499B Market Cap.

Company Description

Coca-Cola Hellenic Bottling Company S.A. engages in the production, sale, and distribution of alcohol-free beverages primarily in Europe. It principally operates as a bottler of The Coca-Cola Company's products. The company offers sparkling, still, and water beverages, as well as combined still and water beverages, including juices, waters, sports and energy drinks, and other ready-to-drink bevera...
more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

Barclays Reiterates "Equal weight" Rating for Coca Cola HBC AG (CCH)
WKRB News - Aug 28, 2014
Also, Barclays reiterated its overweight rating on shares of Diageo plc (ADR). Finally, Barclays lowered its price target on shares of Mobile TeleSystems OJSC (ADR) from $20.50 to $20.20. Coca Cola HBC AG (LON:CCH) opened at 1389.00 on Tuesday.
Coca Cola HBC AG Stock Rating Reaffirmed by Credit Suisse (CCH)
Mideast Time - Aug 8, 2014
Finally, Credit Suisse reiterated its neutral rating on shares of National Grid plc (ADR). Coca Cola HBC AG (LON:CCH) traded down 1.00% on Thursday, hitting GBX 1289.00.
Barclays Reiterates Equal weight Rating for Coca Cola HBC AG (CCH)
Intercooler - Aug 26, 2014
Coca Cola HBC AG logo Barclays reissued their equal weight rating on shares of Coca Cola HBC AG (LON:CCH) in a research note issued to investors on Tuesday morning.
Don't Miss: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Sirius XM Holdings ...
WallStreet Scope - Aug 11, 2014
On August 5, 2014, ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) reported financial results for the second quarter 2014 ended June 30, 2014.